DiagnoCure announces results of its Annual General and Special Meeting of shareholders
In 2008. the Corporation launched a colorectal cancer staging test through its U.S. laboratory.
GTCR Teams with Carl Hull and Eric Tardif to Create Maravai Life Sciences
GTCR will invest up to of equity capital to support management's strategy. Hull is a thirty-year veteran of the diagnostic and life sciences industry.
GTCR Announces Partnership With Carl Hull and Eric Tardif to Form Maravai Life Sciences
GTCR will invest up to led a strategic transformation that focused the company's resources on its core growth areas of clinical diagnostics and laboratory automation.
DiagnoCure Announces First Quarter 2014 Results
DiagnoCure, Inc. today reported financial and operational results for the first quarter 2014 ended per share for this quarter.
Research and Markets: Global HPV Testing Market 2014-2018: Acquisitions and Challenges Discussed
The analysts forecast the Global HPV Testing market to grow at a CAGR of 19.43 percent over the period 2013-2018.